Chief Financial Officer @ (January 2021 - July 2022)
Vice President, Finance and Interim Principle Financial Officer @ Akcea Therapeutics (acquired by Ionis Pharmaceuticals in 2020) (January 2019 - December 2020)
Vice President, Head of Financial Planning and Analysis @ (January 2016 - December 2019)
Senior Director, Finance @ (January 2013 - December 2016)
Vice President, Finance and Treasury @ (January 2012 - December 2013)
Executive Director, Financial Planning and Analysis @ (January 2010 - December 2012)
Senior Director, Financial Planning and Analysis @ (January 2008 - December 2010)
Director, Financial Planning and Analysis @ (January 2007 - December 2008)
Director of Finance @ (January 2005 - December 2007)
Senior Manager, Operations Finance @ (January 2003 - December 2005)
Manager, Corporate Business Analysis @ (January 2000 - December 2003)
Rob Dolski Education
University of Pennsylvania
BS (Civil Engineering and Economics)
The Wharton School
MBA (Finance)
Rob Dolski Skills
Financial Analysis
Financial Reporting
Strategic Financial Planning
M&A experience
Business Development
Treasury Management
Portfolio Management
Lifesciences
Biotechnology
Corporate Development
Global Alliance Management
Strategic Partnerships
Cash Flow Forecasting
Business Planning
Strategy
Sarbanes-Oxley Act
Pharmaceutical Industry
Finance
Financial Modeling
Venture Capital
Investor Relations
Mergers & Acquisitions
Commercialization
Leadership
Budgets
Corporate Finance
Due Diligence
Cross-functional Team Leadership
Managerial Finance
Analysis
Valuation
Acquisition Integration
Forecasting
Biopharmaceuticals
Competitive Analysis
Executive Management
Start-ups
Product Management
Cost Accounting
Management
Financial Planning
Business Analysis
Cross Functional Team Leadership
Start Ups
Project Management
Strategic Planning
Mergers and Acquisitions
Sarbanes Oxley Act
Rob Dolski Summary
Rob Dolski, based in Boston, MA, US, is currently a Chief Financial Officer at Autolus Ltd.. Rob Dolski brings experience from previous roles at Odyssey Therapeutics, Checkmate Pharmaceuticals, Akcea Therapeutics (acquired by Ionis Pharmaceuticals in 2020) and Moderna Therapeutics. Rob Dolski holds a BS in Civil Engineering and Economics @ University of Pennsylvania. With a robust skill set that includes Financial Analysis, Financial Reporting, Strategic Financial Planning, M&A experience, Business Development and more. Rob Dolski has 3 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Rob Dolski?
Find contact details for 700 million professionals.